Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Eur Urol. 2017 Apr;71(4):643-647. doi: 10.1016/j.eururo.2016.06.005. Epub 2016 Jul 12.
Robotic single-site retroperitoneal renal surgery has the potential to minimize the morbidity of standard transperitoneal and multiport approaches. Traditionally, technological limitations of non-purpose-built robotic platforms have hindered the application of this approach.
To assess the feasibility of retroperitoneal renal surgery using a new purpose-built robotic single-port surgical system.
DESIGN, SETTING, AND PARTICIPANTS: This was a preclinical study using three male cadavers to assess the feasibility of the da Vinci SP1098 surgical system for robotic laparoendoscopic single-site (R-LESS) retroperitoneal renal surgery.
We used the SP1098 to perform retroperitoneal R-LESS radical nephrectomy (n=1) and bilateral partial nephrectomy (n=4) on the anterior and posterior surfaces of the kidney. Improvements unique to this system include enhanced optics and intelligent instrument arm control. Access was obtained 2cm anterior and inferior to the tip of the 12th rib using a novel 2.5-cm robotic single-port system that accommodates three double-jointed articulating robotic instruments, an articulating camera, and an assistant port.
The primary outcome was the technical feasibility of the procedures, as measured by the need for conversion to standard techniques, intraoperative complications, and operative times.
All cases were completed without the need for conversion. There were no intraoperative complications. The operative time was 100min for radical nephrectomy, and the mean operative time was 91.8±18.5min for partial nephrectomy. Limitations include the preclinical model, the small sample size, and the lack of a control group.
Single-site retroperitoneal renal surgery is feasible using the latest-generation SP1098 robotic platform. While the potential of the SP1098 appears promising, further study is needed for clinical evaluation of this investigational technology.
In an experimental model, we used a new robotic system to successfully perform major surgery on the kidney through a single small incision without entering the abdomen.
机器人单部位经腹膜后肾手术有可能将标准经腹腔和多孔方法的发病率降至最低。传统上,非专用机器人平台的技术限制阻碍了这种方法的应用。
评估使用新型专用机器人单端口手术系统进行经腹膜后肾手术的可行性。
设计、设置和参与者:这是一项使用 3 具男性尸体的临床前研究,旨在评估达芬奇 SP1098 手术系统用于机器人腹腔镜单部位(R-LESS)经腹膜后肾手术的可行性。
我们使用 SP1098 在肾脏的前后面进行经腹膜后 R-LESS 根治性肾切除术(n=1)和双侧部分肾切除术(n=4)。该系统的独特改进包括增强的光学效果和智能器械臂控制。通过一种新型 2.5 厘米机器人单端口系统获得进入,该系统位于第 12 肋尖端前 2 厘米和下 2 厘米处,可容纳三个双铰接关节机器人器械、一个铰接式相机和一个辅助端口。
主要结果是通过需要转换为标准技术、术中并发症和手术时间来衡量的手术的技术可行性。
所有病例均无需转换即可完成。无术中并发症。根治性肾切除术的手术时间为 100 分钟,部分肾切除术的平均手术时间为 91.8±18.5 分钟。局限性包括临床前模型、样本量小以及缺乏对照组。
使用最新一代 SP1098 机器人平台,单部位经腹膜后肾手术是可行的。虽然 SP1098 的潜力似乎很有前景,但需要进一步研究来评估这种实验性技术的临床应用。
在一个实验模型中,我们使用一种新的机器人系统通过一个小切口成功地对肾脏进行了主要手术,而无需进入腹部。